Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 499 entries
View as:

Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00899509 Org: User:
Start: 10/31/00 End: 02/28/11 Due: 02/28/12

Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003762 Org: User:
Start: 02/28/99 End: 05/31/08 Due: 05/31/09

Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00976573 Org: User:
Start: 04/30/10 End: 09/30/15 Due: 09/30/16

Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00005601 Org: User:
Start: 10/31/00 End: 02/29/08 Due: 02/28/09

Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01517971 Org: User:
Start: 01/31/12 End: 02/27/19 Due: 02/27/20

Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003566 Org: User:
Start: 09/30/98 End: 03/31/06 Due: 03/31/07

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00430183 Org: User:
Start: 05/08/07 End: 10/31/30 Due: 10/31/31

Genetic Markers in Patients With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00014079 Org: User:
Start: 09/30/97 End: 05/31/05 Due: 05/31/06

LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006007 Org: User:
Start: 12/31/00 End: 05/31/08 Due: 05/31/09

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

Phase: N/A Priority: Normal
NCT ID: NCT00417040 Org: User:
Start: 12/31/06 End: 06/01/17 Due: 06/01/18

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00028925 Org: User:
Start: 11/30/01 End: 08/31/08 Due: 08/31/09

Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00022646 Org: User:
Start: 08/31/01 End: 10/31/08 Due: 10/31/09

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00003600 Org: User:
Start: 12/31/98 End: 01/31/10 Due: 01/31/11

Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma

Phase: N/A Priority: Normal
NCT ID: NCT03224767 Org: User:
Start: 01/05/18 End: 08/01/28 Due: 08/01/29

Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001

Phase: N/A Priority: Normal
NCT ID: NCT00954655 Org: User:
Start: 12/31/08 End: 04/30/13 Due: 04/30/14

Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00897182 Org: User:
Start: 05/31/08 End: 03/31/14 Due: 03/31/15

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00075855 Org: User:
Start: 04/30/04 End: 10/31/07 Due: 10/31/08

Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00227565 Org: User:
Start: 02/28/06 End: 10/31/09 Due: 10/31/10

Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00892177 Org: User:
Start: 10/31/09 End: 07/01/19 Due: 07/01/20

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01156142 Org: User:
Start: 12/31/10 End: 03/02/15 Due: 03/02/16

Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00020943 Org: User:
Start: 06/30/01 End: 09/30/09 Due: 09/30/10

Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003829 Org: User:
Start: 08/31/99 End: 10/31/08 Due: 10/31/09

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00521001 Org: User:
Start: 01/31/08 End: 12/31/10 Due: 12/31/11

Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00070486 Org: User:
Start: 12/31/03 End: 05/31/11 Due: 05/31/12

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00509041 Org: User:
Start: 08/31/07 End: 12/31/12 Due: 12/31/13